Polycystic ovary syndrome in women using valproate: A review
Authors:
- Leonilda BiloLBLeonilda Bilo
- Roberta MeoRMRoberta Meo
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 24 (10) , 562-570
Abstract
Valproate (VPA) is a highly effective drug successfully employed in several neuropsychiatric diseases. In the last 15 years, an increased prevalence of polycystic ovary syndrome (PCOS) associated with VPA use has been reported in both women with epilepsy and women with bipolar disorders. However, data on this subject are contrasting and it is possible that different factors might play a role in the development of PCOS in these patients. The risk of developing PCOS during VPA treatment seems to be higher in women with epilepsy than in women with bipolar disorders, and this might be due to an underlying neuroendocrine dysfunction related to the seizure disorder. Gynecologists must be aware of the possibility that PCOS in these populations of patients might be related to VPA use, and a careful multi-specialist approach is required for evaluating the risks and benefits of this treatment in the presence of features of PCOS.Keywords
This publication has 64 references indexed in Scilit:
- Sodium Valproate, Hyperandrogenism and Altered Ovarian Function in Indian Women with Epilepsy: A Prospective StudyEpilepsia, 2007
- The reproductive conditions and lipid profile in females with epilepsyActa Neurologica Scandinavica, 2007
- Characterization of Insulin Secretion in Valproate‐treated Patients with EpilepsyEpilepsia, 2006
- Epilepsy and polycystic ovary syndrome: where is the link?Neurological Sciences, 2006
- Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effectsPhysiological Genomics, 2005
- Polycystic Ovary Syndrome and EpilepsyDrugs, 2003
- Polycystic ovary syndrome: it is always bilateral?Ultrasound in Obstetrics & Gynecology, 1999
- Valproate and palmitate binding to serum albumin in valproate-treated patients. relation to obesityEpilepsy Research, 1993
- Sodium Valproate-Induced Menstrual Disturbance in Young WomenHormone Research, 1991
- Effects of sodium valproate in 100 children with special reference to weight.BMJ, 1981